Affordable Access

Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information.

Authors
  • Bacher, Ulrike
  • Haferlach, Torsten
  • Kern, Wolfgang
  • Hiddemann, Wolfgang
  • Schnittger, Susanne
  • Schoch, Claudia
Type
Published Article
Journal
Annals of hematology
Publication Date
Apr 01, 2005
Volume
84
Issue
4
Pages
250–257
Identifiers
PMID: 15692838
Source
Medline
License
Unknown

Abstract

In chronic myeloproliferative disorders other than CML (CMPD) recurrent cytogenetic abnormalities occur, but specific patterns of chromosomal aberrations in the specific entities have so far not been detected. Thus, the value of conventional cytogenetics in the routine diagnostic setting of CMPD remains to be clarified. We performed a cytogenetic study on 409 patients with different CMPD [polycythemia vera, essential thrombocytosis (ET), idiopathic osteomyelofibrosis, chronic myelomonocytic leukemia (proliferative subtype), idiopathic hypereosinophilic syndrome (HES), myeloproliferative syndrome (unclassifiable)] and on 102 patients with suspected CMPD. Cytogenetic abnormalities occurred in different frequencies ranging from 3 to 40% depending on the subtype, and showed some specific differences with respect to their type. The highest frequency and the most complex pattern of clonal aberrations were observed in idiopathic osteomyelofibrosis. However, clonal aberrations were also found in 10% of patients with suspected CMPD establishing the diagnosis of a malignant disease. In conclusion, cytogenetics are essential in the routine diagnostic setting of CMPD or cases suspicious for CMPD. In ET and in HES the aberration rate was only 3 and 7%, respectively. Thus, cytogenetics can be omitted. However, in some of these cases molecular procedures should be integrated into the routine diagnostic process.

Report this publication

Statistics

Seen <100 times